Browse the full record of transactions filed by Loerop James, Vice-Président Exécutif du Développement Commercial. Insider active across 2 companies, notably Anika Therapeutics, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was filed on 8 July 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
James Loerop is the EVP of Business Development at Anika Therapeutics, Inc. In this role, he is responsible for formulating and executing the company's business development strategies. James Loerop collaborates closely with internal teams and external partners to identify new market opportunities and strengthen Anika's position in the biotechnology industry. His expertise in business development is crucial for achieving the company's growth objectives.